ArticleResearch square2025
Reusability Report: Meta-Learning for Antigen-Specific T-Cell Receptor Binder Identification.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate prediction of peptide-T-cell receptor (TCR) binding is vital for immunotherapy, vaccine design, and diagnostics. PanPep, a meta-learning framework, was developed to generalize diverse TCR binder predictions. This study presents a comprehensive and unbiased evaluation of PanPep's reusability and practical utility. We reproduced its reported performance on original datasets and further benchmarked it against the control tools using both classification metrics and virtual screening enrichment evaluations. Leveraging a newly curated independent dataset, we have demonstrated PanPep's superior generalization to unseen antigens with few or no known TCR binders. We further extended PanPep to peptide-TCRα and peptide-TCRαβ binding prediction, demonstrating its applicability in more biologically and physiologically relevant contexts. Despite its strengths, PanPep shows limitations in early binder enrichment and reduced robustness to novel TCRs, indicating sensitivity to training data composition and negative sampling strategies. This work establishes a reproducible and extensible benchmarking framework for general peptide-TCR binding prediction and related applications. Overall, our study suggests substantial room for improvement in TCR binder prediction, particularly concerning its practical applicability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.